Gemita 1000 mg Injection contains Gemcitabine, a potent antineoplastic (chemotherapy) agent used to treat various types of cancers, including non-small cell lung cancer (NSCLC), pancreatic cancer, breast cancer, ovarian cancer, and bladder cancer. It belongs to the class of antimetabolites, interfering with DNA synthesis in cancer cells and preventing their growth and spread.

• Broad-spectrum efficacy in treating solid tumors

• Can be used alone or in combination with other chemotherapy drugs

• Improves tumor response rates and patient outcomes

• May help slow disease progression and extend survival

• Administered as a slow intravenous (IV) infusion

• Infusion usually takes around 30 minutes

• Given under supervision of a qualified oncologist in a clinical setting

• Dosing frequency varies by type and stage of cancer

• Strength: 1000 mg Gemcitabine per vial

• Form: Lyophilized powder for reconstitution

• Route: Intravenous infusion

• Frequency: Typically administered weekly or biweekly depending on the treatment protocol

• Only to be administered by healthcare professionals

• Regular monitoring of blood counts, liver and kidney function is essential

• Avoid use in pregnancy and lactation

• Use cautiously in patients with bone marrow suppression or liver disease

• Stay hydrated and follow supportive care measures during therapy

• Common: Fatigue, nausea, vomiting, flu-like symptoms, anemia, leukopenia

• Less common: Mouth sores, rash, liver enzyme elevation

• Serious: Lung toxicity, kidney impairment, allergic reactions, thrombocytopenia

• Contact your doctor immediately for symptoms like fever, unusual bleeding, or breathing difficulties

• Store unopened vial below 25°C, protected from light

• Use reconstituted solution as advised by healthcare provider or manufacturer

• Keep out of reach of children and do not freeze

Q1. What is Gemita 1000 mg used for?
A: It’s prescribed for treating several cancers, including lung, pancreatic, bladder, breast, and ovarian cancers.

Q2. Can Gemcitabine be taken orally?
A: No, it must be administered intravenously by a trained medical professional.

Q3. How often is Gemcitabine 1000 mg given?
A: Dosing varies; typically given once weekly for 2–3 weeks, followed by a rest period.

Q4. Can this injection be used during pregnancy?
A: No, it is contraindicated during pregnancy due to risk of fetal harm.

Q5. How is the dose of Gemcitabine calculated?
A: Based on the patient’s body surface area (BSA) and overall health condition.